Cedars-Sinai Medical Center
Hospital, FunderROROpenAlexWikidata
People
Hyung L Kim
Chair, department of urology
Physician and director
Larissa Gutman Paranhos Langhi Prata
Research scientist
Professor and vice-dean
Director
Assistant professor
Linda ostrowski chair in hematology onco
Associate professor and medical director
Arun Sharma
Associate professor
Chen Yuan
Professor
Director, translational science inst
Assistant professor
Director center for adv gerotherapeutics
Professor
Medical oncology
Professor / research sci. iii
Anjaparavanda P Naren
Professor
Chair, department of cardiology
Sources: reporter.nih.gov
Founded
Founded
Jun 30, 1902
Sources: search.gleif.org
Trials
EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease
Not yet recruiting, 170 people
Barber and Pharmacist Coordination to Improve Blood Pressure Management
Not yet recruiting, 55 people, Oct 5, 2026
5-Fluorouracil and Calcipotriene for Field Treatment of Actinic Keratoses
Phase 1, Not yet recruiting, 96 people, Aug 31, 2026
Ongoing Lung Decline With Age Intensified Response
Phase 2, Recruiting, 40 people, Jun 30, 2026
Phenotype Guided Vasoactive Medication During Kidney Transplantation
Collaborator, Phase 4, Enrolling by invitation, 255 people, Jun 8, 2026
Phase 2, Not yet recruiting, 36 people, May 13, 2026
Phase 2, Not yet recruiting, 20 people, May 5, 2026
Phase 2, Not yet recruiting, 94 people, Mar 27, 2026
Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
Recruiting, 45 people, Nov 4, 2025
Phase 2, Recruiting, 80 people, Oct 31, 2025
Phase 2, Recruiting, 34 people, Jun 12, 2025
Phase 1/2, Not yet recruiting, 60 people, Nov 12, 2024
Phase 2, Recruiting, 60 people, Aug 23, 2024
Phase 2, Recruiting, 140 people, May 31, 2024
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Phase 2, Not yet recruiting, 30 people, Feb 14, 2024
Phase 2, Completed, 20 people, Nov 15, 2023
Collaborator, Phase 2/3, Recruiting, 336 people, Oct 26, 2023
Impact of Protect Your Colon™ on CRC Screening
Completed, 184 people, Jul 3, 2023
LEAPTogether: An Intergenerational Intervention to Address Loneliness and Social Isolation
Completed, 16 people, Apr 26, 2023
Early phase 1, Recruiting, 90 people, Mar 16, 2023
Sources: clinicaltrials.gov
Grants and prizes
R01, Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer, R01CA280060, $692K, 2023–2028, Sep 17, 2026
P30, Los Angeles Claude D. Pepper Older Americans Independence Center, P30AG094848, $1.3M, 2025–2030, Sep 17, 2026
K01, Research Continuity Supplement K01AG090692, K01AG090692, $75.1K, 2025–2030, Sep 11, 2026
National Heart, Lung, and Blood Institute
R01, Dynamic Predictors of Sudden Cardiac Death, R01HL181473, $1.7M, 2026–2028, Sep 9, 2026
National Heart, Lung, and Blood Institute
R01, Role of the Endocannabinoid System, Metabolic Disease Progression, and Associated Cardiovascular Risk, R01HL184098, $854K, 2026–2030, Aug 31, 2026
R01, Federated Transfer Learning Framework to Improve Genetic Risk Prediction for Alzheimer's Disease and Related Dementias, R01AG094962, $809K, 2026–2031, Aug 25, 2026
National Institute of Allergy and Infectious Diseases
R21, Vascular niche restoration to prevent delayed effects of acute radiation exposure (DEARE) in the hematopoietic system, R21AI193964, $167K, 2025–2027, Aug 21, 2026
U54, The Microvascular Aging Effects - Women's Evaluation of Systemic aging Tenacity in Heart, Brain and Frailty (MAE-WEST HBF) ("You are never too old to become younger!"), U54AG094168, $1.5M, 2025–2030, Aug 20, 2026
UG3, Using microgravity to model inflammaging in complex organ chip models of heart, gut, and brain, UG3AG099469, $1.2M, 2025–2028, Aug 18, 2026
K22, Etiology and Tumor Characteristics of Early-onset Pancreatic Cancer, K22CA288914, $192K, 2025–2028, Aug 7, 2026
R01, Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes, R01CA280081, $681K, 2023–2028, Jul 28, 2026
R35, Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance, R35CA283706, $918K, 2024–2031, Jul 22, 2026
R01, p53 acetylation drives alveolar progenitor cells senescence in progressive pulmonary fibrosis, R01AG097434, $671K, 2026–2031, Jul 17, 2026
R01, Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with Metformin, R01AG089711, $712K, 2024–2029, Jul 15, 2026
R33, Translational Geroscience Network, R33AG061456, $702K, 2019–2029, Jul 14, 2026
National Institute of Diabetes and Digestive and Kidney Diseases
RC2, Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy, RC2DK140862, $2M, 2024–2029, Jul 7, 2026
R21, A phase I trial of S-Adenosylmethionine (SAMe) for chemoprevention of colorectal adenomas, R21CA313077, $340K, 2026–2028, Jun 30, 2026
R01, Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina, R01AG055865, $803K, 2018–2028, Jun 18, 2026
R01, Impact of exogenous hormones on Prostate Cancer Risk, Detection, and Outcomes in the Nationwide Veterans Affairs Health System, R01CA300694, $647K, 2026–2031, Jun 16, 2026
National Institute of Diabetes and Digestive and Kidney Diseases
R01, Inhibition of an Apical cAMP/cGMP Transporter (MRP4) in the Gut Induces Diarrhea, R01DK080834, $576K, 2009–2028, Jun 3, 2026
Sources: reporter.nih.gov
Grants and prizes awarded
Hydrogen Sulfide and GLP-1 Combination Therapy to Treat HFpEF (sub-award to THE REGENTS OF THE UNIVERSITY OF COLORADO), usaspending_subaward/ASST_NON_R01HL181016_075/MW8JHK6ZYEX8, $61.6K, 2026, Jul 21, 2026
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators (sub-award to PRESIDENT AND FELLOWS OF HARVARD COLLEGE), usaspending_subaward/ASST_NON_R01CA258222_075/UNVDZNFA8R29, $50.9K, 2026, Apr 2, 2026
The University of Texas at Arlington
The Microvascular Aging Effects (sub-award to UNIVERSITY OF TEXAS AT ARLINGTON), usaspending_subaward/ASST_NON_U54AG094168_075/LMLUKUPJJ9N3, $37.3K, 2026, Apr 2, 2026
California Institute of Technology
Hypothalamic Pathways of Age Related Homeostatic Dysregulation (sub-award to CALIFORNIA INSTITUTE OF TECHNOLOGY), usaspending_subaward/ASST_NON_RF1AG091203_075/U2JMKHNS5TG4, $66.9K, 2026, Jan 22, 2026
Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy (sub-award to RUTGERS, THE STATE UNIVERSITY), usaspending_subaward/ASST_NON_RC2DK140862_075/M1LVPE5GLSD9, $438K, 2025, Aug 27, 2025
Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy (sub-award to REGENTS OF THE UNIVERSITY OF MICHIGAN), usaspending_subaward/ASST_NON_RC2DK140862_075/GNJ7BBP73WE9, $875K, 2025, Mar 4, 2025
Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy (sub-award to BAYLOR COLLEGE OF MEDICINE), usaspending_subaward/ASST_NON_RC2DK140862_075/FXKMA43NTV21, 2025, Feb 13, 2025
Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy (sub-award to BAYLOR COLLEGE OF MEDICINE), usaspending_subaward/ASST_NON_RC2DK140862_075/FXKMA43NTV21, $881K, 2025, Lead, Feb 13, 2025
Sources: openalex.org
Funded papers
Oct 25, 2026
Human Y chromosome pan-organ mapping reveals progressive mosaic loss from normal to cancer
Sep 8, 2026
UL1TR001108, Aug 31, 2026
UL1TR001108, U54 AG065141, Aug 26, 2026
Aug 19, 2026
Aug 1, 2026
Artificial Intelligence Use in Menopause Care
Jul 30, 2026
Jul 8, 2026
Jun 6, 2026
May 27, 2026
Genomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome
Apr 23, 2026
Apr 11, 2026
Mar 11, 2026
Mar 5, 2026
Feb 18, 2026
Feb 17, 2026
Area deprivation, social vulnerability, and post-pregnancy blood pressure
Feb 12, 2026
Heart Failure Prevention: Evidence Generation, Trial Design, and Regulatory Pathways
Feb 11, 2026
A deep ensemble encoder network method for improved polygenic risk score prediction
Jan 24, 2026
Jan 20, 2026
Sources: api.crossref.org, openalex.org
Named in competing interests
Patents or royalties, Oct 30, 2026
Patents or royalties, Oct 23, 2026
Fees or honoraria, Grants or research support, Oct 1, 2026
Patents or royalties, Aug 1, 2026
Patents or royalties, Grants or research support, Jul 8, 2026
Additive prognostic value of functional performance to coronary artery anatomy: the ISCHEMIA trial
Patents or royalties, Apr 30, 2026
Educational and Socioeconomic Inequality and Cardiovascular Risk in Peru: A Cross-Sectional Analysis
Grants or research support, Mar 19, 2026
Patents or royalties, Mar 10, 2026
Grants or research support, Mar 6, 2026
Heart Failure Prevention: Evidence Generation, Trial Design, and Regulatory Pathways
Grants or research support, Feb 11, 2026
Falls predict faster progression to Alzheimer's dementia
Fees or honoraria, Feb 1, 2026
Grants or research support, Aug 13, 2025
Grants or research support, Aug 13, 2025
Grants or research support, Feb 19, 2025
Grants or research support, Feb 18, 2025
Antigen-specific age-related memory CD8 T cells induce and track Alzheimer's-like neurodegeneration
Patents or royalties, Jul 12, 2024
Patents or royalties, Apr 28, 2022
Patents or royalties, Dec 23, 2020
Sources: pubmed.ncbi.nlm.nih.gov
Papers
Asia-Pacific journal of clinical oncology, Nov 14, 2026
Senescent cell heterogeneity: The impact of targeting senescent endothelial cells in obesity
Geromedicine, Nov 13, 2026
Comprehensive healthspan assessments and influence of sex as a biological variable in aging rats
Aging, Nov 11, 2026
Scientific reports, Nov 11, 2026
Blood-based RNA biomarker for the early detection of ovarian cancer
Nature medicine, Nov 10, 2026
Proteomic and Autoantibody Signatures Link Coronary Plaque with ApoB-Related Immune Dysregulation
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
Leading causes of death differed by stroke type in survivors
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
Associations Between Antenatal Stress and Postpartum Insulin Resistance
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
Very high heart artery calcium linked to higher death risk
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
Diet-linked blood proteins tied to cardiovascular disease risk
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
arXiv, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
The Impact of Clonal Hematopoiesis Variants on Cardiovascular Outcomes and Metabolic Profiles
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026